Search Results - Paul Frankel
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a... by Mark Kirschbaum, Kenneth A. Foon, Paul Frankel, Christopher Ruel, Bernadette Pulone, Joseph M. Tuscano, Edward M. Newman
Published 2013Artigo -
7
Chondroitin sulphate‐modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas‐mediated pathway... by Paul Frankel, Caroline Pellet‐Many, Pauliina Lehtolainen, Giovanna M. D’Abaco, Michelle Tickner, Lili Cheng, Ian Zachary
Published 2008Artigo -
8
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors by Sumanta K. Pal, Sierra M. Li, Xiwei Wu, Hanjun Qin, Marcin Kortylewski, Joann Hsu, Courtney Carmichael, Paul Frankel
Published 2015Artigo -
9
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage... by George Somlo, Sean K. Lau, Paul Frankel, Huangpin B. Hsieh, Xiaohe Liu, Lixin Yang, Robert T. Krivacic, Richard H. Bruce
Published 2011Artigo -
10
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma by Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara
Published 2009Artigo -
11
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial by Tianhong Li, Scott Christensen, Paul Frankel, Kim Margolin, Sanjiv S. Agarwala, Thehang Luu, Philip C. Mack, Primo N. Lara, David R. Gandara
Published 2010Artigo -
12
Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling by Antonina Frolov, Ian Evans, Ningning Li, Kastytis Šidlauskas, Ketevan Paliashvili, Nicola Lockwood, Angela N. Barrett, Sebastian Brandner, Ian Zachary, Paul Frankel
Published 2016Artigo -
13
-
14
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma by Warren Chow, Paul Frankel, Chris Ruel, Dejka M. Araujo, Mohammed Milhem, Scott H. Okuno, Lee Hartner, Samir D. Undevia, Arthur P. Staddon
Published 2019Artigo -
15
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial by Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara
Published 2010Artigo -
16
Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin by Ahmad A. Tarhini, Paul Frankel, Kim Margolin, Scott Christensen, Christopher Ruel, Janice Shipe-Spotloe, David R. Gandara, Alice P. Chen, John M. Kirkwood
Published 2011Artigo -
17
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation by Helen M. Jopling, Adam F. Odell, Caroline Pellet‐Many, Antony M. Latham, Paul Frankel, Asipu Sivaprasadarao, John H. Walker, Ian Zachary, Sreenivasan Ponnambalam
Published 2014Artigo -
18
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers by Vincent Chung, Ferdynand Kos, Nicola Hardwick, Yuan Yuan, Joseph Chao, D. Li, James Waisman, Minzhao Li, Kathryn Zurcher, Paul Frankel, Don J. Diamond
Published 2018Artigo -
19
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid‐derived suppressor cells for <i>Agaricus bisporus</i>–in... by Przemyslaw Twardowski, Noriko Kanaya, Paul Frankel, Timothy W. Synold, Christopher Ruel, Sumanta K. Pal, Maribel Junqueira, Manisha Prajapati, Tina Moore, P. Tryon, Shiuan Chen
Published 2015Artigo -
20
Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using <sup>64</sup>Cu-DOTA-Trastuzumab PET by Joanne Mortimer, James R. Bading, David Colcher, Peter S. Conti, Paul Frankel, Mary Carroll, Shan Tong, Erasmus Poku, Joshua K. Miles, John E. Shively, Andrew Raubitschek
Published 2013Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Biology
Biochemistry
Cancer research
Gene
Chemotherapy
Gastroenterology
Breast cancer
Cell biology
Adverse effect
Clinical trial
Chemistry
Pathology
Signal transduction
Surgery
VEGF receptors
Clinical endpoint
Immunology
Vascular endothelial growth factor
Genetics
Phases of clinical research
Receptor
Tolerability
Immunotherapy
Metastatic breast cancer
Pharmacology
Cisplatin